Read + Share
Eser K, Onder AH, Sezer E, Cil T, et al. Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in
metastatic breast cancer patients based on an observational study. BMC Cancer 2022;22:516.
PMID: 35525929
|
 |
|
Eser K, Onder AH, Sezer E, Cil T, et al. Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in
metastatic breast cancer patients based on an observational study. BMC Cancer 2022;22:516.
PMID: 35525929
|
|
|
|